-
Mashup Score: 49Living Guidelines - 1 year(s) ago
Living Guidelines
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 47Living Guidelines - 1 year(s) ago
Living Guidelines
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
We’ve issued a living guideline update on therapy for stage IV #NSCLC without driver alterations: https://t.co/8BJHh9p0pt #lungcancer #lcsm https://t.co/ee1DQYZgpy
-
-
Mashup Score: 15
The President’s Cancer Panel issued a report on Feb. 28 on the National Cancer Plan that highlights seven ASCO programs that are contributing to the plan.
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
We're honored to be included in the new @PresCancerPanel report on the #NationalCancerPlan, which highlights 7 ASCO programs contributing to the plan & its aim of achieving @POTUS Cancer Moonshot goal of “ending cancer as we know it.” More: https://t.co/KPvwkBPjBH #Every1HasARole https://t.co/9gZOtJqlsx
-
-
Mashup Score: 6All Award Recipients - 1 year(s) ago
All Award Recipients
Source: old-prod.asco.orgCategories: General Medicine News, Hem/OncsTweet-
RT @GlopesMd: Join us in congratulating and thanking all @ASCO #ASCO20 new FASCO and special award recipients https://t.co/xGnA9Mycn0 https…
-
-
Mashup Score: 16
The American Society of Clinical Oncology (ASCO)’s new policy statement highlights the need for formalized efforts to address health-related social needs and outlines ways to address social
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
Just released: New ASCO policy statement highlights the need for formalized efforts to address health-related social needs and outlines ways to address #SocialDeterminantsofHealth in cancer care: https://t.co/7O7UUlLsT1 #ASCOHealthEquity @RegTuckSee https://t.co/p5rV4x2PfM
-
-
Mashup Score: 131Fellow of the American Society of Clinical Oncology - 1 year(s) ago
Formerly called the ASCO Statesman Award, the Fellow of the American Society of Clinical Oncology (FASCO) distinction recognizes ASCO members for their extraordinary volunteer service, dedication, and commitment to ASCO. Their efforts benefit ASCO, the specialty of oncology, and, most importantly, the patients for whom they serve.
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
🎉 Join us in congratulating the following members on earning the Fellow of ASCO (FASCO) distinction this quarter! We're grateful for your extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about the FASCO distinction: https://t.co/gjfBJHxnmj https://t.co/HKmDzkUoo4
-
-
Mashup Score: 46ASCO's Advocacy Toolkit - 1 year(s) ago
The Association for Clinical Oncology (ASCO) is committed to assisting individual oncologists advocate for effective policies for providing the best quality care to cancer patients. How initial and
Source: old-prod.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Productive day at @ASCO HQ with the Gov't Relations Cmte covering important #ASCOAdvocacy priorities including drug shortages, federal funding, ARPA-H, AI and so much more. Get involved in ASCO’s advocacy efforts: https://t.co/Y5W6UjONVV https://t.co/hgYM5RCuud
-
-
Mashup Score: 45ASCO's Advocacy Toolkit - 1 year(s) ago
The Association for Clinical Oncology (ASCO) is committed to assisting individual oncologists advocate for effective policies for providing the best quality care to cancer patients. How initial and
Source: old-prod.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Productive day at @ASCO HQ with the Gov't Relations Cmte covering important #ASCOAdvocacy priorities including drug shortages, federal funding, ARPA-H, AI and so much more. Get involved in ASCO’s advocacy efforts: https://t.co/Y5W6UjONVV https://t.co/hgYM5RCuud
-
-
Mashup Score: 7CDK4/6 Inhibitor Dosing Knowledge (CDK) Study - 1 year(s) ago
Comparing Oral Drug Dosing Strategies in Older Patients with Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation Content last updated on December 11, 2023. This study is not currently recruiting or enrolling participants. About the CDK Study The CDK Study will analyze different starting dose levels of CDK4/6 inhibitors, a type of targeted therapy, in patients 65 and older…
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
CMO Dr. @jrgralow highlights our plans to study dosing for CDK4/6 inhibitors in pts 65+ w HR+/HER2- metastatic #breastcancer. Learn more 👉 https://t.co/fnWXqFcClH https://t.co/dt289y215V
-
-
Mashup Score: 27ASCO Plenary Series Program - 1 year(s) ago
Learn more about the faculty and program for the February Plenary Series session.
Source: old-prod.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
Just announced! The February #ASCOPlenarySeries will highlight: ⭐ Phase 3 DREAMM-7 findings in multiple myeloma ⭐ Phase 3 FRUTIGA findings in GI cancers Tune in February 6. Details: https://t.co/vQ7mKAfQDQ #mmsm #gicsm @Oncoalert @SoniSmithMD @FlorianLordick https://t.co/mr3W4679hF
-
We’ve issued a living guideline update on therapy for stage IV #NSCLC without driver alterations: https://t.co/8BJHh9p0pt #lungcancer #lcsm https://t.co/ee1DQYZgpy